Skip to main content
Caplight Logo









Diagnoly

Diagnoly

Private
LyonHealthcare & Life Scienceshttps://diagnoly.com

Last Round

Seed

Apr 8, 2025

Total Funding Raised

$7.28M

Company Overview

Diagnoly operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Seed round in April 2025.

Diagnoly is a medtech company that provides an AI-powered software platform designed to improve prenatal ultrasound screening.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Medical Devices, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Revenue Share, Freemium

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Diagnoly Comparables

Compare Diagnoly with similar companies based on industry and business-model similarity.

Diagnoly comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioticsAI
92%
BrightHeart
92%
Fraiya
89%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Diagnoly Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 8, 2025
Pre SeedDec 1, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Diagnoly Investors

Notable investors and investment history

Diagnoly investors
InvestorRounds
Les Business Angels des Grandes ÉcolesPre Seed, Seed
Harvard Innovation LabsPre Seed
Newfund CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Grew 53% QoQ, from 15 to 23 employees.

  • Jan 21, 2026

    Grew 33% QoQ from 15 to 20 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Diagnoly Filings

Explore SEC and related filing metadata, where available.

Diagnoly filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Diagnoly's valuation, stock price, and market status.

Is Diagnoly a public or private company?

Diagnoly is a private company.

What is the current stock price of Diagnoly?

Diagnoly is a private company, so its shares have no public market price. Caplight tracks Diagnoly's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Diagnoly worth (valuation)?

Valuation information for Diagnoly is not publicly available.

Can I buy Diagnoly stock?

Diagnoly shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Diagnoly's last funding round?

Diagnoly's most recent funding round was Seed on April 8, 2025.

Who are the main investors in Diagnoly?

Key investors in Diagnoly include Newfund Capital.

Will Diagnoly IPO soon?

No public IPO plans have been announced for Diagnoly.

How can I track Diagnoly secondary market activity?

Caplight tracks bids, offers, and trades in Diagnoly's shares on secondary markets.

Firmographic Details

HeadquartersLyon
Employee Range23
Year Founded2020
Last FundingApr 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?